Leverage Shares - 3x China Tech
KWE3.L
London Stock Exchange- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Leverage Shares 3x Long China Tech ETC (KWE3.L) is an exchange-traded commodity (ETC) issued by Leverage Shares Management Company Ltd that provides three times the daily performance of the Solactive China New Economy Tech Index, net of fees and expenses. The product offers leveraged exposure to leading Chinese technology companies including those in e-commerce, internet services, software, and semiconductors such as Alibaba Group Holding Ltd, Tencent Holdings Ltd, Meituan, and PDD Holdings Inc; it employs physical replication through swaps with institutional counterparties to achieve its daily leveraged target. Leverage Shares, founded in 2018 and headquartered in London, United Kingdom, with additional offices in Dublin, Ireland, specializes in a range of single-stock and thematic leveraged and inverse ETPs listed on the London Stock Exchange and Deutsche Boerse; the firm targets sophisticated investors seeking amplified returns on equities, sectors, and indices across global markets including the US, Europe, and Asia. The company operates primarily in Europe through regulated platforms, serving institutional and retail investors interested in short-term trading strategies with high volatility amplification. In recent developments, Leverage Shares expanded its product suite in 2024-2025 with new launches including additional 3x and -3x leveraged ETPs on US technology giants and emerging market themes, alongside strategic partnerships with market makers to enhance liquidity amid volatile equity conditions. No major acquisitions or funding rounds were reported in the last 1-2 years, though the firm continues to optimize its swap counterparty arrangements for risk management and cost efficiency in response to evolving regulatory standards under UCITS and PRIIPs frameworks.